SG3 Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,000
Closed -$191K 493
2019
Q4
$191K Sell
1,000
-1,500
-60% -$271K 0.01% 193
2019
Q3
$421K Buy
2,500
+500
+25% +$81.5K 0.04% 187
2019
Q2
$335K Sell
2,000
-500
-20% -$69.2K 0.04% 257
2019
Q1
$366K Buy
+2,500
New +$362K 0.04% 205
2018
Q1
Sell
-7,200
Closed -$1.18M 153
2017
Q4
$1.18M Buy
7,200
+3,900
+118% +$700K 0.39% 48
2017
Q3
$676K Hold
3,300
0.16% 93
2017
Q2
$802K Hold
3,300
0.2% 113
2017
Q1
$788K Sell
3,300
-2,700
-45% -$629K 0.14% 104
2016
Q4
$1.26M Buy
+6,000
New +$1.24M 0.2% 86

Other funds holding AGN

SG3 Management's AGN Position: Q1 2020 in Review

SG3 Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,000 shares — an estimated $191K sold.

SG3 Management first reported a position in AGN in Q4 2016 and held it in 9 quarters. The position peaked at $1.26M in Q4 2016. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • SG3 Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • SG3 Management sold 1,000 Allergan plc shares in Q1 2020, an estimated $191K.
  • SG3 Management first reported a position in Allergan plc in Q4 2016 and held it in 9 quarters.
  • SG3 Management's Allergan plc position peaked at $1.26M in Q4 2016.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on SG3 Management's 13F filing for Q1 2020, filed 12 May 2020.